Efficacy of implantable cardioverter-defibrillators: from trials to the real world [0.03%]
植入式心脏除颤器的有效性：从临床试验到实际应用
João De Sousa
João De Sousa
Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias [0.03%]
植入型心律转复除颤器置入后发生室性快速性心律失常的严重左室功能不全患者的长期临床预后研究
Nuno Pelicano,Mário Oliveira,Nogueira Da Silva et al.
Nuno Pelicano et al.
Left ventricular ejection fraction (LVEF) is accepted as an important prognostic marker in patients (pts) with implantable cardioverter-defibrillators (ICD). The impact of this therapeutic approach in the survival of pts with life-threateni...
Patrícia Costa,Ana Carriço,José Monterroso et al.
Patrícia Costa et al.
Jorge Guardado,Carlos Cotrim,Berta Pontes et al.
Jorge Guardado et al.
António Vaz Carneiro
António Vaz Carneiro
The determination of causality is crucial in medicine: for example, a doctor who prescribes a therapeutic regimen believes that it will cure the disease. Causality in medicine is complex, since it can be difficult to establish a cause-effec...
Francisco Alpendurada,João Carlos Mota,Jorge Puig
Francisco Alpendurada
Pericardial cysts are uncommon and benign abnormalities, usually asymptomatic, whose main interest lies in differential diagnosis with other mediastinal tumors. The authors present a case report of a 40-year-old male with a symptomatic peri...
Eisenmenger syndrome in the adult--experience with new drugs for the treatment of pulmonary hypertension [0.03%]
艾森曼格综合征的治疗——应用新药治疗肺动脉高压的经验总结
Ana Figueiredo Agapito,Lídia Sousa,José Alberto Oliveira et al.
Ana Figueiredo Agapito et al.
Background: The last few years have seen significant progress in the treatment of advanced pulmonary arterial hypertension (PAH). The efficacy of new drugs has been proved mainly in idiopathic PAH or PAH associated with c...
A Pinheiro Vieira,Pedro Pulido Adragão,Katya Res Santos et al.
A Pinheiro Vieira et al.
Background: Hypertrophic cardiomyopathy is a genetic disease inherited as an autosomal dominant trait associated with risk of sudden death. The majority of cases of sudden death occur in young adults with no or few sympto...
Selective pulmonary vasodilators for severe pulmonary hypertension: comparison between endpoints [0.03%]
特异性肺血管扩张剂治疗严重肺动脉高压的疗效比较：来自临床试验终点的不同观点
Joana Feliciano,Duarte Cacela,Ana Agapito et al.
Joana Feliciano et al.
The therapeutic approach to severe pulmonary arterial hypertension (PAH), whether primary or secondary to connective tissue disorders, thromboembolic phenomena or congenital heart disease with Eisenmenger syndrome, has evolved in recent yea...
Catarina Pereira,Peter Vogelaere
Catarina Pereira
Introduction: Coronary heart disease is one of the principal causes of death and morbidity in the western world, and particularly in Portugal. Objectives:...